TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Tempus Stock

Tempus Stock

tempus.comHealthcareFounded: 2015Funding to Date: $826.22MM

Tempus is a biotechnology company focused on making precision medicine a reality by applying AI in healthcare, deriving insights from an expansive library of clinical data and molecular data.

Buy or sell Tempus stockLearn more about Tempus IPO
Register for Details

For more details on financing and valuation for Tempus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tempus.

Register Today

Team

Management Team

Kevin White, Ph.D.
Chief Science Officer
Vanessa Rollings
Chief Financial Officer
Eric Lefkofsky
Founder & Chief Executive Officer
Ryan Fukushima
Chief Operating Officer
Marc Yoskowitz
Chief Strategy Officer
Mike Yasiejko
Chief Commercial Officer
Gary Palmer, MD
Chief Medical Officer
Shane Colley
Chief Technology Officer
Chief Strategy Officer
Chief People Officer

Board Members

David Agus, MD
A. Keith Stewart, MB.CHB., MBA
Steve Case
Revolution
Arul M. Chinnaiyan, MD, Ph.D.
Peter Barris
New Enterprise Associates
Funmi Olopade, MD
Eric Topol, MD
John Doerr
Kleiner Perkins

Other companies like Tempus in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

Genomeweb 04/12/2022
Tempus, Pyramid Biosciences to ID Patients With NTRK Fusion-Driven Cancers for Clinical Trial
Pyramid will use Tempus' TIME Trial Network to identify and enroll patients eligible for a Phase I/II trial of its TRK inhibitor, PBI-200.
Chicago Business 03/16/2020
Illinois cruise passengers can't come home yet • Layoffs at Weiss, West Suburban • Tempus to expand beyond cancer
Crunchbase 03/16/2020
Chicago-Based Tempus Raises $100M At $5B Valuation For AI-Driven Healthcare
Groupon co-founder Eric Lefkofsky started Tempus in September 2015. This round comes comes less than 10 months after the startup raised $200 million.

Trending Companies

Frequently Asked Questions

Updated on: Jun 1, 2023